Previous research (30, 31) has demonstrated that the ALI score is a powerful prognostic and predictive marker for advanced NSCLC lung cancer patients treated with PD-L1 inhibitors alone but not in combination with chemotherapy. The gene discussed is CD274; the disease is lung carcinoma.